Madalina Huruba

Study design, process and outcome indicators of post‐authorization studies aimed at evaluating the effectiveness of risk minimization measures in the EU PAS Register

C. Mogoșan, Andreea Farcas, Madalina Huruba, 2019, British journal of clinical pharmacology.

Survery of healthcare professionals to assess the awareness, knowledge and self-reported behavior regarding recent fluoroquinolones safety issues

D. Leucuta, C. Mogoșan, Madalina Huruba, 2021, Medicine and pharmacy reports.

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders

D. Leucuta, C. Mogoșan, Madalina Huruba, 2022, Pharmaceuticals.

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly

D. Leucuta, C. Mogoșan, Madalina Huruba, 2021, Pharmaceuticals.

A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders

D. Leucuta, C. Mogoșan, Madalina Huruba, 2021, Scientific Reports.

Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients—An Observational Retrospective Study

D. Dumitrascu, C. Mogoșan, Madalina Huruba, 2023, Pharmaceuticals.